⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodomethane SCHEMBL118500 | 0.83 | — | — | |
| Iodomethane SCHEMBL799995 | 0.83 | — | — | |
| Iodomethane SCHEMBL28473371 | 0.77 | — | — | |
| Iodomethane SCHEMBL3415879 | 0.72 | — | — | |
| Ethane SCHEMBL29691387 | 0.55 | — | — | |
| Ethane SCHEMBL1331172 | 0.55 | — | — | |
| Ethane SCHEMBL4877482 | 0.55 | — | — | |
| Ethane SCHEMBL18184927 | 0.55 | — | — | |
| Ethane SCHEMBL21175041 | 0.55 | — | — | |
| Methylamine SCHEMBL1332656 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1079 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115920785-A | Catalytic production equipment for deuterated iodomethane | 山东法拉第氘源科技有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-113582976-B | Deuterated 2-substituted aniline-4-indolyl pyrimidine derivative and preparation method and application thereof | 郑州大学 | 2023-03-17 | — | — | CN | claimed |
| CN-113582976-A | Deuterated 2-substituted aniline-4-indolyl pyrimidine derivative and preparation method and application thereof | 郑州大学 | 2021-11-02 | — | — | CN | claimed |
| CN-113493466-A | Stable isotope labeled ofloxacin and synthetic method thereof | 上海安谱实验科技股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| US-12622917-B2 | High-activity Wnt pathway inhibitor compound | ADLAI NORTYE BIOPHARMA CO., LTD. (CN) | 2026-05-12 | — | — | US | disclosed |
| US-12612383-B2 | Polysubstituted pyrrolidine derivative, preparation method therefor and use thereof | SHANGHAI WENNAI THERAPEUTICS CO., LTD. (CN) | 2026-04-28 | — | — | US | disclosed |
| US-20260022100-A1 | NAV1.8 INHIBITOR | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) | 2026-01-22 | — | — | US | disclosed |
| US-20250325557-A1 | 3, 7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE | WISTA LABORATORIES LTD. (SG) | 2025-10-23 | — | — | US | disclosed |
| US-20250296922-A1 | POLYSUBSTITUTED PYRROLIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI WENNAI THERAPEUTICS CO LTD (CN) | 2025-09-25 | — | — | US | disclosed |
| US-20250230128-A1 | DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE | CYBIN IRL LIMITED (IE) | 2025-07-17 | — | — | US | disclosed |
| EP-4585599-A1 | NITROGEN-CONTAINING FUSED RING COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | Hangzhou Synrx Therapeutics Biomedical Technology Co., Ltd. (CN) | 2025-07-16 | — | — | EP | disclosed |
| US-20250179093-A1 | KRAS MODULATORS | ALTEROME THERAPEUTICS, INC. | 2025-06-05 | — | — | US | disclosed |
| US-7157456-B2 | Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer | BAYER HEALTHCARE AG (DE) | 2007-01-02 | — | — | US | disclosed |
| US-7157451-B2 | Heterocyclic dihydropyrimidine compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-01-02 | — | — | US | disclosed |
| US-7157469-B2 | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same | AVANIR PHARMACEUTICALS (US) | 2007-01-02 | — | — | US | disclosed |
| EP-1729814-A2 | PEGYLATED ION CHANNEL MODULATING COMPOUNDS | Cardiome Pharma Corp. (CA) | 2006-12-13 | — | — | EP | disclosed |
| US-20060276408-A1 | Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins | MYRIAD GENETICS, INCORPORATED (US) | 2006-12-07 | — | — | US | disclosed |
| US-20060183790-A1 | Azolylacylguanidines as beta-secretase inhibitors | WYETH (US) | 2006-08-17 | — | — | US | disclosed |
| WO-2005094897-A2 | PEGYLATED ION CHANNEL MODULATING COMPOUNDS | CARDIOME PHARMA CORP. (CA) | 2005-10-13 | — | — | WO | disclosed |
| US-20040102472-A1 | Method of preparing inhibitors of phosphodiesterase-4 | MERCK & CO., INC. | 2004-05-27 | — | — | US | disclosed |